Clene to include ALS biomarker data in NDA for accelerated approval

Go back to Clene to include ALS biomarker data in NDA for accelerated approval
(NASDAQ: CLNN) Delayed: 3.85 +0.09 (2.39%)
Previous Close $3.76    52 Week High $ 
Open $3.73    52 Week Low $ 
Day High $4.01    P/E N/A 
Day Low $3.73    EPS $ 
Volume 72,440